Edison Investment Research

Innate Pharma

New anti-inflammatory and anti-cancer progress

Update | Pharmaceutical & Healthcare | 24/05/2013

A preclinical anti-TLR3 candidate in IPH33 (anti-inflammatory) has been selected for preclinical studies, which is now ready for partnering. Meanwhile,…

Petrominerales

Moving forward

QuickView | Oil & Gas | 24/05/2013

Following a frustrating FY12, which saw declines in both production and reserves, Petrominerales is moving forward with a lower-risk drilling programme…

CytRx Corporation

Focus turns to aldoxorubicin

Update | Pharmaceutical & Healthcare | 24/05/2013

CytRx is now focused on fully exploiting the potential of aldoxorubicin in advanced soft tissue sarcoma (STS) following the failure of tamibarotene. The…

Gulfsands Petroleum

Re-rating potential of Fés

Update | Oil & Gas | 24/05/2013

Gulfsands has successfully diversified its business away from Syria and now operates in Morocco, Tunisia and Colombia. We increase our 2014 RENAV to 121p…

SCISYS

In-line trading update

Flash note | Technology | 24/05/2013

In a brief trading update released in conjunction with its AGM, SCISYS has said it is on track to meet full-year guidance. Having begun the year with a…

More research

EMED Mining

Rio Tinto’s geological potential

Outlook | Mining | 23/05/2013

Alexza Pharmaceuticals

Stage set for Adasuve

QuickView | Pharmaceutical & Healthcare | 23/05/2013

Aastrom Biosciences

Patients and cash

Update | Pharmaceutical & Healthcare | 23/05/2013

NetDimensions

Growth acceleration

Update | Technology | 22/05/2013

LSL Property Services

Accelerated investment on market recovery

Update | Property | 22/05/2013

Is Yatirim Menkul Degerler

Challenging year-on-year comparatives

Update | Financials | 22/05/2013

Fair Value REIT

Rationalising and reinvesting

Outlook | Property | 22/05/2013

Optimal Payments

Strong trading continues

Update | Technology | 22/05/2013

Optos

Don’t panic

QuickView | Pharmaceutical & Healthcare | 21/05/2013